EUDA Health Holdings Limited (NASDAQ: EUDA) ('EUDA” or the 'Company”), a Singapore-based non-invasive healthcare provider in ...

Hopstem Biotechnology, a clinical-stage biotech specializing in iPSC-derived cell therapeutics for neurological diseases, has ...

Exploring the differentiation of iPSC to trunk tenocytes and how the single-cell RNA sequencing and pathway analysis can assist in making it more specific.

Researchers in Zurich say they have developed a method to use microrobots delivering stem cell therapies to treat spinal cord ...

Shinya Yamanaka didn’t want to get ahead of himself the first time he looked at induced pluripotent stem cells (iPSCs) through a microscope. “Don’t be excited,” he told his colleague Kazutoshi ...

The site includes laboratories for cell culture manufacturing, process development, and a centre focused on gene editing.

Researchers developed a novel approach to treating spinal cord injuries: controllable microrobots deliver stem cells directly ...

These iPS cells have the potential to differentiate into various types of nervous system cells. The nanoparticles consist of two layers: an inner layer that responds to magnetic fields and an outer ...

FT836 demonstrates meaningful reduction in target lesions without the use of conditioning chemotherapy in metastatic colorectal cancerDetection ...

Fujifilm Corp. announced May 19 that it had opened a new human-induced pluripotent stem cell (iPSC) factory in Madison, ...